BHUBANESWAR: Digambar Behera, Odisha native and PGIMER Chandigarh professor, has been nominated a member of the clinical research group formulated under the National Task Force for Covid-19 by Indian Council of Medical Research (ICMR).
AIIMS New Delhi director Randeep Guleria leads the six-member group.
Behera, a professor of pulmonary medicine, said the group will meet very soon. “We are in the process of quick information gathering. We will discuss how the disease is behaving in different ways in different countries. What is causing death and evolve the clinical practice that is needed for India,” Dr Behera told TOI.
There will also be more focused approach towards the hydroxychloroquine, which many consider as a potential drug for Covid-19. Even if a clinical randomization trial may not be possible given the urgency, efforts will be more to scientifically find out how HCQ is working,” he said.
A Padma Shree awardee, Behera is an alumnus of SCB Medical College. He is known as a pioneer of lung cancer chemotherapy. He is the founder president of the Indian Study for the Study of Lung Cancer.
He has published over 462 papers and has received many awards. He has been working more towards TB elimination and lung cancer treatment. He is Fellow of Indian College of Physicians, International College of Angiology, Indian Chest Society and Indian Society of Oncology.
AIIMS New Delhi director Randeep Guleria leads the six-member group.
Behera, a professor of pulmonary medicine, said the group will meet very soon. “We are in the process of quick information gathering. We will discuss how the disease is behaving in different ways in different countries. What is causing death and evolve the clinical practice that is needed for India,” Dr Behera told TOI.
There will also be more focused approach towards the hydroxychloroquine, which many consider as a potential drug for Covid-19. Even if a clinical randomization trial may not be possible given the urgency, efforts will be more to scientifically find out how HCQ is working,” he said.
A Padma Shree awardee, Behera is an alumnus of SCB Medical College. He is known as a pioneer of lung cancer chemotherapy. He is the founder president of the Indian Study for the Study of Lung Cancer.
He has published over 462 papers and has received many awards. He has been working more towards TB elimination and lung cancer treatment. He is Fellow of Indian College of Physicians, International College of Angiology, Indian Chest Society and Indian Society of Oncology.
Coronavirus outbreak
Trending Topics
LATEST VIDEOS
More from TOI
Navbharat Times
Featured Today in Travel
Quick Links
Kerala Coronavirus Helpline NumberHaryana Coronavirus Helpline NumberUP Coronavirus Helpline NumberBareilly NewsBhopal NewsCoronavirus in DelhiCoronavirus in HyderabadCoronavirus in IndiaCoronavirus symptomsCoronavirusRajasthan Coronavirus Helpline NumberAditya ThackerayShiv SenaFire in MumbaiAP Coronavirus Helpline NumberArvind KejriwalJammu Kashmir Coronavirus Helpline NumberSrinagar encounter
Get the app